Exelixis
EXEL
#1601
Rank
ยฃ8.26 B
Marketcap
ยฃ29.54
Share price
-1.29%
Change (1 day)
68.58%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company